CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58% Full year revenue […]
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology […]
Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling […]
Oatly Launches Two New Oatmilk Varieties, Marking the Company’s First Major Innovations to its Core North American Beverage Portfolio in Five Years
MALMÖ, Sweden, Jan. 08, 2024 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and […]
GlobalFoundries Announces Conference Call to Review Fourth Quarter and Full-Year 2023 Financial Results
MALTA, N.Y., Jan. 08, 2024 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call […]
Evaxion Announces Plan to Implement ADS Ratio Change
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio […]
TSX News -
Globex Receives Payments to Finalize Uranium Property Acquisition by Infini Resources
ROUYN-NORANDA, Quebec, Jan. 08, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]
Vladimir Wendl Ibarra joins Earth Alive’s Board of Directors
MONTREAL, Jan. 08, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC – “Earth Alive” or the “Company”), […]
NRSInsights’ December 2023 Retail Same-Store Sales Report
Same-store sales at NRS retailers during December increased 5.5% compared to December 2022 Compared to November 2023, same-store-sales per calendar […]
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO
DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK; NHWK), an integrated contract development and manufacturing […]
